Literature DB >> 17068779

Phosphorylation of CREB and DARPP-32 during late LTP at hippocampal to prefrontal cortex synapses in vivo.

Maïté Hotte1, Sébastien Thuault, Kelly T Dineley, Hugh C Hemmings, Angus C Nairn, Thérèse M Jay.   

Abstract

Specific patterns of stimulation applied in the ventral hippocampus produce long-term potentiation (LTP) of postsynaptic synapses in the prefrontal cortex in vivo. The induction of LTP is dependent on NMDA receptors and cAMP-dependant kinase (PKA) activation. Yet little is known concerning the cellular mechanisms underlying the expression of this neocortical form of LTP. In the present study, we tested whether LTP at hippocampal to prefrontal cortex synapses leads to activation of DARPP-32 and CREB as well as defined the temporal regulation of the phosphorylation states of both proteins. Our data indicate a peak in CREB and DARPP-32 phosphorylation during the late phase of prefrontal LTP (2 h posttetanus). These findings support the hypothesis that prolonged expression of hippocampal-prefrontal cortex LTP depends on a synergistic mechanism involving phosphorylation of both CREB and DARPP-32 via activation of the cAMP/PKA-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17068779     DOI: 10.1002/syn.20339

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  13 in total

1.  Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex.

Authors:  Mahomi Kuroiwa; Gretchen L Snyder; Takahide Shuto; Atsuo Fukuda; Yuchio Yanagawa; David R Benavides; Angus C Nairn; James A Bibb; Paul Greengard; Akinori Nishi
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

Review 2.  GSK-3β activity and hyperdopamine-dependent behaviors.

Authors:  Yan-Chun Li; Wen-Jun Gao
Journal:  Neurosci Biobehav Rev       Date:  2010-08-18       Impact factor: 8.989

3.  α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases.

Authors:  Zane S Martin; Volker Neugebauer; Kelly T Dineley; Rakez Kayed; Wenru Zhang; Lindsay C Reese; Giulio Taglialatela
Journal:  J Neurochem       Date:  2011-11-28       Impact factor: 5.372

4.  Bidirectional synaptic plasticity and spatial memory flexibility require Ca2+-stimulated adenylyl cyclases.

Authors:  Ming Zhang; Daniel R Storm; Hongbing Wang
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

5.  dCREB2-mediated enhancement of memory formation.

Authors:  Thomas C Tubon; Jiabin Zhang; Eugenia L Friedman; Haining Jin; Erin D Gonzales; Hong Zhou; Diana Drier; Jason R Gerstner; Emily A Paulson; Robin Fropf; Jerry C P Yin
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

6.  Selective induction of calcineurin activity and signaling by oligomeric amyloid beta.

Authors:  Lindsay C Reese; WenRu Zhang; Kelly T Dineley; Rakez Kayed; Giulio Taglialatela
Journal:  Aging Cell       Date:  2008-09-08       Impact factor: 9.304

7.  Administration of the calcineurin inhibitor cyclosporine modulates cocaine-induced locomotor activity in rats.

Authors:  Nii A Addy; Amine Bahi; Jane R Taylor; Marina R Picciotto
Journal:  Psychopharmacology (Berl)       Date:  2008-06-28       Impact factor: 4.530

8.  Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison.

Authors:  Justine Renard; Marie-Odile Krebs; Thérèse M Jay; Gwenaëlle Le Pen
Journal:  Psychopharmacology (Berl)       Date:  2012-09-16       Impact factor: 4.530

9.  DARPP-32 expression in rat brain after an inhibitory avoidance task.

Authors:  Daniela V F Rosa; Renan P Souza; Bruno R Souza; Melissa M Guimarães; Daniel S Carneiro; Samira S Valvassori; Marcus V Gomez; João Quevedo; Marco A Romano-Silva
Journal:  Neurochem Res       Date:  2008-04-16       Impact factor: 3.996

Review 10.  The Yin and Yang of dopamine release: a new perspective.

Authors:  Yukiori Goto; Satoru Otani; Anthony A Grace
Journal:  Neuropharmacology       Date:  2007-07-19       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.